ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 627,45
-0,63%
Dow Jones
39 335,24
-0,10%
DAX
18 472,05
0,06%
Brent Oil
85,375
-1,31%
Bitcoin
56 184,81
0,61%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Apyx Medical Corporation (APYX)

  7. Apyx Medical Corporation (APYX) Actualités

APYX

Apyx Medical (APYX)

Apyx Medical Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:APYX
DateHeureSourceTitreSymboleSociété
26/06/202413h30PR Newswire (US)Apyx Medical Corporation Launches the "Renewing Lives" Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental HealthNASDAQ:APYXApyx Medical Corporation
31/05/202420h49Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:APYXApyx Medical Corporation
09/05/202418h14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APYXApyx Medical Corporation
09/05/202416h05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:APYXApyx Medical Corporation
09/05/202413h45Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:APYXApyx Medical Corporation
09/05/202413h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APYXApyx Medical Corporation
09/05/202413h05Business WireApyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial OutlookNASDAQ:APYXApyx Medical Corporation
09/05/202413h00Business WireApyx Medical Corporation Announces Board Leadership TransitionNASDAQ:APYXApyx Medical Corporation
25/04/202413h30Business WireApyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024NASDAQ:APYXApyx Medical Corporation
11/04/202413h30Business WireApyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ SummitNASDAQ:APYXApyx Medical Corporation
21/03/202412h00Business WireApyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial OutlookNASDAQ:APYXApyx Medical Corporation
04/03/202413h30Business WireApyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024NASDAQ:APYXApyx Medical Corporation
21/02/202413h30Business WireApyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific MeetingNASDAQ:APYXApyx Medical Corporation
14/02/202423h06Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:APYXApyx Medical Corporation
23/01/202415h52Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:APYXApyx Medical Corporation
22/01/202413h30Business WireApyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the BodyNASDAQ:APYXApyx Medical Corporation
11/01/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APYXApyx Medical Corporation
08/01/202413h00Business WireApyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue ResultsNASDAQ:APYXApyx Medical Corporation
28/11/202314h30Business WireApyx Medical Corporation Appoints Matthew Hill as Chief Financial OfficerNASDAQ:APYXApyx Medical Corporation
16/11/202323h29Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:APYXApyx Medical Corporation
09/11/202313h01Business WireApyx Medical Corporation Announces New Debt Facility with Perceptive AdvisorsNASDAQ:APYXApyx Medical Corporation
09/11/202313h00Business WireApyx Medical Corporation Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial OutlookNASDAQ:APYXApyx Medical Corporation
07/11/202313h30Business WireApyx Medical Corporation to Participate in Upcoming Investor Conferences in NovemberNASDAQ:APYXApyx Medical Corporation
02/10/202313h30Business WireApyx Medical Corporation to Release Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023NASDAQ:APYXApyx Medical Corporation
10/08/202322h05Business WireApyx Medical Corporation Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial OutlookNASDAQ:APYXApyx Medical Corporation
29/06/202322h42Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:APYXApyx Medical Corporation
29/06/202322h42Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:APYXApyx Medical Corporation
29/06/202322h05Business WireApyx Medical Corporation to Release Second Quarter of Fiscal Year 2023 Financial Results on August 10, 2023NASDAQ:APYXApyx Medical Corporation
28/06/202320h02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APYXApyx Medical Corporation
21/06/202316h54Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:APYXApyx Medical Corporation
 Showing the most relevant articles for your search:NASDAQ:APYX

Dernières Valeurs Consultées

EU
SGO
Cie de SaintGobain
NASDAQ
AMZN
Amazon.com
EU
PX1
CAC 40
EU
RNO
Renault
EU
AI
Air Liquide
COIN
ETHUSD
Ethereum
EU
RI
Pernod Ricard
NASDAQ
NVDA
NVIDIA
EU
AF
Air FranceKLM
NASDAQ
GOOGL
Alphabet
EU
BEL20
Bel 20
EU
MC
Lvmh Moet Hennessy Louis...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés